Health Care & Life Sciences » Pharmaceuticals | YiChang HEC ChangJiang Pharmaceutical Co. Ltd.

YiChang HEC ChangJiang Pharmaceutical Co. Ltd.

YiChang HEC ChangJiang Pharmaceutical Co. Ltd.
Stock Exchange Hong Kong Stock Exchange
EPS
HKD2.5
Market Cap
HKD18.65 B
Shares Outstanding
226.2 M
Public Float
130.89 M

Profile

Address
Dong YangGuang Park
Dongguan Guangdong 443300
China
Employees -
Website http://www.hec-changjiang.com
Updated 07/08/2019
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. engages in the development, manufacturing and selling of pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases, cardiovascular diseases and others. Its products include Benzbromarone, Telmisartan, Amlodipine besylate, and Cetirizine hydrochloride. The company was founded on May 11, 2015 and is headquartered in Dongguan, China.

Financials

View All
Created with Highcharts 5.0.14YiChang HEC ChangJiang Pharmaceutical Co. Ltd.Net Income. Fiscal year is January-December. All values HKD Millions.73731701703283284454457467461 1161 116201320142015201620172018025050075010001250
Created with Highcharts 5.0.14YiChang HEC ChangJiang Pharmaceutical Co. Ltd.Sales/Revenue. Fiscal year is January-December. All values HKD Millions.3993995555558558551 1001 1001 8471 8472 9742 9742013201420152016201720180500100015002000250030003500

Fang Fang Huang
Chairman-Supervisory Board
Xin Fa Tang
Chairman